VD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Recent advances and current challenges in hydrophilic interaction chromatography for the analysis of therapeutic oligonucleotides | TrAC. Trends in analytical chemistry | 2024 | 79 | 43 | |||
| Assessment of chemical stability of monoclonal antibody and antibody drug conjugate administered by pressurized intraperitoneal aerosol chemotherapy | Journal of pharmaceutical and biomedical analysis | 2024 | 19 | 7 | |||
| Optimizing Messenger RNA Analysis Using Ultra-Wide Pore Size Exclusion Chromatography Columns | International journal of molecular sciences | 2024 | 64 | 40 | |||
| Boosting the Separation of Adeno-Associated Virus Capsid Proteins by Liquid Chromatography and Capillary Electrophoresis Approaches | International journal of molecular sciences | 2023 | 115 | 65 | |||
| Enhancing Selectivity of Protein Biopharmaceuticals in Ion Exchange Chromatography through Addition of Organic Modifiers | International journal of molecular sciences | 2023 | 104 | 29 | |||
| High-throughput chromatographic separation of oligonucleotides: a proof of concept using ultra-short columns | Analytical chemistry | 2023 | 80 | 88 | |||
| Why is there no biosimilar of Erbitux®? | Journal of pharmaceutical and biomedical analysis | 2023 | 218 | 307 | |||
| Tackling Issues Observed during the Development of a Liquid Chromatography Method for Small Molecule Quantification in Antibody-Chelator Conjugate | Molecules | 2023 | 189 | 85 | |||
| Chromatographic strategies for the analytical characterization of adeno-associated virus vector-based gene therapy products | TrAC. Trends in analytical chemistry | 2023 | 88 | 220 | |||
| Comprehensive evaluation of zwitterionic hydrophilic liquid chromatography stationary phases for oligonucleotide characterization | Journal of chromatography | 2023 | 108 | 339 | |||
| Interlaboratory Evaluation of a User-Friendly Benchtop Mass Spectrometer for Multiple-Attribute Monitoring Studies of a Monoclonal Antibody | Molecules | 2023 | 117 | 106 | |||
| Anion-Exchange Chromatography at the Service of Gene Therapy: Baseline Separation of Full/Empty Adeno-Associated Virus Capsids by Screening of Conditions and Step Gradient Elution Mode | International journal of molecular sciences | 2022 | 205 | 114 | |||
| Boosting the Liquid Chromatography Separation of Complex Bispecific Antibody Products by Using the Multi-Isocratic Elution Mode | Separations | 2022 | 158 | 142 | |||
| Bispecific antibody characterization by a combination of intact and site-specific/chain-specific LC/MS techniques | Talanta (Oxford) | 2022 | 198 | 170 | |||
| A New Practice to Monitor the Fabrication Process of Fab-Targeting Ligands from Bevacizumab by LC-MS: Preparation and Analytical Characterization | Scientia pharmaceutica | 2022 | 181 | 102 | |||
| The impact of low adsorption surfaces for the analysis of DNA and RNA oligonucleotides | Journal of chromatography | 2022 | 228 | 213 | |||
| Ultra-fast middle-up reversed phase liquid chromatography analysis of complex bispecific antibodies obtained in less than one minute | Pharmaceutics | 2022 | 208 | 111 | |||
| Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products | Journal of separation science | 2022 | 202 | 80 | |||
| Quantitative N-Glycan Profiling of Therapeutic Monoclonal Antibodies Performed by Middle-Up Level HILIC-HRMS Analysis | Pharmaceutics | 2021 | 207 | 140 | |||
| Towards a simple on-line coupling of ion exchange chromatography and native mass spectrometry for the detailed characterization of monoclonal antibodies | Journal of chromatography | 2021 | 186 | 312 | |||
| Alternative mobile phase additives for the characterization of protein biopharmaceuticals in liquid chromatography – Mass spectrometry | Analytica Chimica Acta | 2021 | 441 | 246 | |||
| Therapeutic Fc‐fusion proteins: Current analytical strategies | Journal of Separation Science | 2021 | 385 | 1,621 | |||
| State-of-the-Art Native Mass Spectrometry and Ion Mobility Methods to Monitor Homogeneous Site-Specific Antibody-Drug Conjugates Synthesis | Pharmaceuticals | 2021 | 258 | 113 | |||
| Characterization of Glycosylated Proteins at Subunit Level by HILIC/MS | Mass Spectrometry of Glycoproteins. Methods in Molecular Biology | 2021 | 234 | 345 | |||
| The importance of being metal-free: The critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry | Analytica chimica acta | 2021 | 315 | 391 | |||
| Interlaboratory and Interplatform Study of Steroids Collision Cross Section by Traveling Wave Ion Mobility Spectrometry | Analytical Chemistry | 2020 | 376 | 0 | |||
| Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins | Trends in Analytical Chemistry | 2020 | 323 | 207 | |||
| Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities | Journal of Pharmaceutical and Biomedical Analysis | 2020 | 443 | 1 | |||
| Glycan-Mediated Technology for Obtaining Homogeneous Site-Specific Conjugated Antibody-Drug Conjugates: Synthesis and Analytical Characterization by Using Complementary Middle-up LC/HRMS Analysis | Analytical Chemistry | 2020 | 318 | 0 | |||
| Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications | Analytica Chimica Acta | 2019 | 396 | 2 | |||
| The Emergence of Universal Chromatographic Methods in the Research and Development of New Drug Substances | Accounts of Chemical Research | 2019 | 332 | 0 | |||
| Recent Advances in Chromatography for Pharmaceutical Analysis | Analytical Chemistry | 2019 | 611 | 3,733 | |||
| Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future | Expert Review of Proteomics | 2019 | 399 | 0 | |||
| Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates? | Journal of Chromatography. A | 2019 | 475 | 0 | |||
| DNA and RNA telomeric G-quadruplexes: what topology features can be inferred from ion mobility mass spectrometry? | The Analyst | 2019 | 297 | 4 | |||
| Orthogonal Middle-up Approaches for Characterization of the Glycan Heterogeneity of Etanercept by Hydrophilic Interaction Chromatography Coupled to High-Resolution Mass Spectrometry | Analytical Chemistry | 2019 | 432 | 1 | |||
| A generic workflow for the characterization of therapeutic monoclonal antibodies—application to daratumumab | Analytical and Bioanalytical Chemistry | 2019 | 502 | 3 | |||
| Monoclonal antibody N-glycosylation profiling using capillary electrophoresis – Mass spectrometry: Assessment and method validation | Talanta | 2018 | 586 | 441 | |||
| Protocols for the analytical characterization of therapeutic monoclonal antibodies. III – Denaturing chromatographic techniques hyphenated to mass spectrometry | Journal of Chromatography. B | 2018 | 442 | 3 | |||
| Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry | Journal of Chromatography. B | 2018 | 502 | 1 | |||
| Characterizing various monoclonal antibodies with milder reversed phase chromatography conditions | Journal of Chromatography. B | 2018 | 452 | 1 | |||
| Adding a new separation dimension to MS and LC–MS: What is the utility of ion mobility spectrometry? | Journal of Separation Science | 2018 | 602 | 5 | |||
| An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates | Analytical Chemistry | 2018 | 528 | 2 | |||
| Analysis of recombinant monoclonal antibodies in hydrophilicinteraction chromatography: A generic method developmentapproach | Journal of pharmaceutical and biomedical analysis | 2017 | 567 | 499 | |||
| Protocols for the analytical characterization of therapeutic monoclonal antibodies. I - Non-denaturing chromatographic techniques | Journal of Chromatography. B | 2017 | 480 | 7 | |||
| Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation | Journal of Chromatography. B | 2017 | 463 | 6 | |||
| Protocols for the analytical characterization of therapeutic monoclonal antibodies. II – Enzymatic and chemical sample preparation | Journal of chromatography. B | 2017 | 621 | 5 |
